Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: The Italian expanded access program

E. Verzoni, G. Cartenì, E. Cortesi, D. Giannarelli, A. De Giglio, R. Sabbatini, S. Buti, S. Rossetti, F. Cognetti, F. Rastelli, A. Sobrero, D. Turci, C.N. Sternberg, C. Porta, F. Cappuzzo, G. Tortora, D. Tassinari, S. Panni, A. Pazzola, G. SuricoA. Raimondi, U. De Giorgi, G. Procopio

Research output: Contribution to journalArticlepeer-review

Cite this